Health Care & Life Sciences » Medical Equipment & Supplies | AorTech International PLC

AorTech International PLC | Income Statement

Fiscal year is April-March. All values GBP Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
263.30
524.20
498.60
471.30
406.00
Cost of Goods Sold (COGS) incl. D&A
-
206.20
-
-
-
Gross Income
-
318.00
-
-
-
SG&A Expense
541.10
482.00
719.70
419.90
409.80
EBIT
429.60
164.00
428.30
172.70
224.10
Unusual Expense
89.40
46.60
72.40
9.20
255.80
Non Operating Income/Expense
0.60
8.10
99.60
-
64.90
Pretax Income
518.40
202.50
401.00
181.90
33.20
Consolidated Net Income
518.40
202.50
401.00
181.90
33.20
Net Income
518.40
202.50
401.00
181.90
33.20
Net Income After Extraordinaries
212.30
175.20
401.00
181.90
33.20
Net Income Available to Common
824.50
229.80
401.00
181.90
33.20
EPS (Basic)
0.16
0.05
0.08
0.03
0.01
Basic Shares Outstanding
5,092.20
5,092.20
5,303.00
5,856.10
5,856.10
EPS (Diluted)
0.16
0.05
0.08
0.03
0.01
Diluted Shares Outstanding
5,092.20
5,092.20
5,303.00
5,856.10
5,856.10
EBITDA
277.80
42.20
221.10
51.40
3.80

About AorTech International

View Profile
Address
Springfield House
Weybridge Surrey KT13 9LZ
United Kingdom
Employees -
Website http://www.aortech.net
Updated 07/08/2019
AorTech International Plc is a holding company, which engages in the commercialization of biomedical polymer technology, components, and medical devices. It manufactures biostable and implantable polymers under the Elast-Eon and ECSil brands. The company was founded by James Gordon Wright and Edward McDaid in 1992 and is headquartered in Weybridge, the United Kingdom.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.